Sensus Healthcare Q3 revenues down 57% YoY to $3.9M; net loss of $1.5M

Sensus Healthcare, Inc.

2023-Q3 EPS reported -$0.23 revenue$11,838,000

Revenues $3.9M vs $9.0M Q3 2022; net loss $1.5M ($0.09/sh) vs net income $1.8M ($0.11) prior year.
Adjusted EBITDA negative $1.7M vs positive $2.3M a year ago.
Shipped 11 SRT units (3 outside US, 5 to one large customer); cash $20.5M, no debt.
Board approved $3.0M stock repurchase program.
Submitted 510(k) for aesthetic drug delivery system; expects completion by end of 2023.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Sensus Healthcare, Inc. reported the third quarter of 2023 results: revenue $3.9 million, net income Net loss was $1.5 million, EPS $(0.09) per share.

Period: the third quarter of 2023
Revenue: $3.9 million
Net income: Net loss was $1.5 million
EPS: $(0.09) per share
Result: reported results

Exact text from the filing

Sensus Healthcare Reports Third Quarter 2023 Financial Results Revenues of $3.9 million reflect seasonality and macroeconomic conditions

View on SEC.gov

Browse all earnings releases →

Sensus Healthcare, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-085220

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.